SUSAN MOORE: Open Payments
NPI 1770593212 · WYTHEVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$41,072 in 131 payments from 21 companies in 2025. Trend: 2023 $121,540 · 2024 $103,312 · 2025 $41,072
Honoraria: $20,720Speaker / faculty: $17,250Food & beverage: $1,693Travel & lodging: $1,409
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 33 | $22,008 |
| Amgen Inc. | 28 | $10,148 |
| ABBVIE INC. | 22 | $8,002 |
| Novo Nordisk Inc | 11 | $145 |
| Vanda Pharmaceuticals Inc. | 4 | $105 |
| AstraZeneca Pharmaceuticals LP | 6 | $102 |
| Collegium Pharmaceutical, Inc. | 5 | $99 |
| Teva Pharmaceuticals USA, Inc. | 5 | $82 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $68 |
| Lilly USA, LLC | 1 | $66 |
Products named: Auvelity, OTEZLA, VRAYLAR, Jornay PM, AUSTEDO XR, HETLIOZ, UBRELVY, CAPLYTA.
Industry payments across VA — which companies pay providers there.
